[go: up one dir, main page]

NO951865L - Quinuclidine derivative as substance P antagonist - Google Patents

Quinuclidine derivative as substance P antagonist

Info

Publication number
NO951865L
NO951865L NO951865A NO951865A NO951865L NO 951865 L NO951865 L NO 951865L NO 951865 A NO951865 A NO 951865A NO 951865 A NO951865 A NO 951865A NO 951865 L NO951865 L NO 951865L
Authority
NO
Norway
Prior art keywords
substance
antagonist
quinuclidine derivative
diseases
quinuclidine
Prior art date
Application number
NO951865A
Other languages
Norwegian (no)
Other versions
NO951865D0 (en
Inventor
Fumitaka Ito
Hiroshi Kondo
Masami Nakane
Kaoru A Shimad
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1993/006624 external-priority patent/WO1994011368A1/en
Application filed by Pfizer filed Critical Pfizer
Publication of NO951865L publication Critical patent/NO951865L/en
Publication of NO951865D0 publication Critical patent/NO951865D0/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Denne oppfinnelse angår kinuklidin-derivatet (2S,3S)-N- (5-n-propyl-2-metoksyfenyl)metyl-2-difenylmetyl-l-azabicyklo- [2.2.2]oktan-3-amin og dets farmasøytisk akseptable salter. Disse forbindelser er substans-P-antagonister og kan brukes ved behandlingen av sykdommer og lidelser i tarmkanalen, inflammatoriske sykdommer, sykdommer i forbindelse med det sentrale nervesystem, foruten smerte.This invention relates to the quinuclidine derivative (2S, 3S) -N- (5-n-propyl-2-methoxyphenyl) methyl-2-diphenylmethyl-1-azabicyclo [2.2.2] octane-3-amine and its pharmaceutically acceptable salts . These compounds are substance P antagonists and can be used in the treatment of diseases and disorders of the intestinal tract, inflammatory diseases, diseases of the central nervous system, besides pain.

NO951865A 1992-11-12 1995-05-11 Quinuclidine derivative as substance P antagonist NO951865D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97524492A 1992-11-12 1992-11-12
PCT/US1993/006624 WO1994011368A1 (en) 1992-11-12 1993-07-19 Quinuclidine derivative as substance p antagonist

Publications (2)

Publication Number Publication Date
NO951865L true NO951865L (en) 1995-05-11
NO951865D0 NO951865D0 (en) 1995-05-11

Family

ID=26786876

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951865A NO951865D0 (en) 1992-11-12 1995-05-11 Quinuclidine derivative as substance P antagonist

Country Status (2)

Country Link
HK (1) HK1000246A1 (en)
NO (1) NO951865D0 (en)

Also Published As

Publication number Publication date
HK1000246A1 (en) 1998-02-13
NO951865D0 (en) 1995-05-11

Similar Documents

Publication Publication Date Title
MY130145A (en) Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders.
FI935134A0 (en) Substituent 3-aminoquinuclidine
RU93058531A (en) Fluoroalkoxybenzylamine derivatives of nitrogen-containing heterocycles, pharmaceutical composition, method of treatment
BR9917038A (en) Compound, pharmaceutical composition, method of modulating chemokine receptor activity, method of treatment or prevention of inflammatory diseases, method of treatment or prevention of asthma and method of treatment or prevention of inflammatory disorders
MY107157A (en) Quinuclidine derivatives.
HUP0100815A2 (en) Pharmaceutical for treatment of neurological and neuropsychiatric disorders
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
DE69424777D1 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
BR9807950A (en) Compound, pharmaceutical composition, use of a compound, and, processes to treat or reduce the risk of human diseases or conditions, the risk of inflammatory disease, the risk of pain and for the preparation of a compound
NO982863L (en) New compounds with analgesic effect
HUP0103712A2 (en) Salts of paroxetine, process for their preparation and their pharmaceutical use
FI954614A0 (en) Imidazoloquinoxalinone derivatives as EAA antagonists
NO951865L (en) Quinuclidine derivative as substance P antagonist
BG105984A (en) Osanetant in the treatment of mood disorders
ATE402178T1 (en) SUBSTITUTED 5,6,6A,11B-TETRAHYDRO-7-OXA-5-AZA-BENZO-FLUORENE-6-CARBONIC ACID DERIVATIVES AS NMDA ANTAGONISTS
DE69811487D1 (en) BENZOIC ACID DERIVATIVES AND THEIR MEDICAL USE
WO1999019324A3 (en) Antipsychotic substituted piperidine derivatives